TY - JOUR
T1 - Author Correction
T2 - Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy (Nature Medicine, (2022), 28, 3, (557-567), 10.1038/s41591-022-01696-4)
AU - Ganan-Gomez, Irene
AU - Yang, Hui
AU - Ma, Feiyang
AU - Montalban-Bravo, Guillermo
AU - Thongon, Natthakan
AU - Marchica, Valentina
AU - Richard-Carpentier, Guillaume
AU - Chien, Kelly
AU - Manyam, Ganiraju
AU - Wang, Feng
AU - Alfonso, Ana
AU - Chen, Shuaitong
AU - Class, Caleb
AU - Kanagal-Shamanna, Rashmi
AU - Ingram, Justin P.
AU - Ogoti, Yamini
AU - Rose, Ashley
AU - Loghavi, Sanam
AU - Lockyer, Pamela
AU - Cambo, Benedetta
AU - Muftuoglu, Muharrem
AU - Schneider, Sarah
AU - Adema, Vera
AU - McLellan, Michael
AU - Garza, John
AU - Marchesini, Matteo
AU - Giuliani, Nicola
AU - Pellegrini, Matteo
AU - Wang, Jing
AU - Walker, Jason
AU - Li, Ziyi
AU - Takahashi, Koichi
AU - Leverson, Joel D.
AU - Bueso-Ramos, Carlos
AU - Andreeff, Michael
AU - Clise-Dwyer, Karen
AU - Garcia-Manero, Guillermo
AU - Colla, Simona
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/5
Y1 - 2022/5
N2 - In the version of this article initially published, the name of the Edward P. Evans Foundation was shown incorrectly in the first sentence of the Acknowledgements. The name has been corrected in the HTML and PDF versions of the paper.
AB - In the version of this article initially published, the name of the Edward P. Evans Foundation was shown incorrectly in the first sentence of the Acknowledgements. The name has been corrected in the HTML and PDF versions of the paper.
UR - http://www.scopus.com/inward/record.url?scp=85128977272&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85128977272&partnerID=8YFLogxK
U2 - 10.1038/s41591-022-01827-x
DO - 10.1038/s41591-022-01827-x
M3 - Comment/debate
C2 - 35484266
AN - SCOPUS:85128977272
SN - 1078-8956
VL - 28
SP - 1097
JO - Nature medicine
JF - Nature medicine
IS - 5
ER -